IP
Indranil Paul
Oregon Health & Science University Knight Cancer Institute, Broad Institute of MIT and Harvard, University of Calcutta, Boston University School of Medicine
0000-0003-0327-5002
Employment
-
Oregon Health & Science University Knight Cancer Institute Staff Scientist2023 - Present
-
Broad Institute of MIT and Harvard Research Scientist I2022 - 2023
-
Boston University School of Medicine Research Scientist2017 - 2022
-
Beth Israel Deaconess Medical Center Research Fellow2017 - 2018
-
Novo Nordisk Foundation Center for Protein Research Post-doctoral Researcher2013 - 2017
Education
-
University of Calcutta Ph.D2007 - 2013
-
University of Calcutta Master of Science2004 - 2006
-
University of Calcutta Bachelor of Science2001 - 2004
Projects & Funding
Projects & funding information is unavailable.
Publications (17)
- DESP demixes cell-state profiles from dynamic bulk molecular measurements Save
- GPS2-mediated regulation of the adipocyte secretome modulates adipose tissue remodeling at the onset of diet-induced obesity Save
- Parallelized multidimensional analytic framework applied to mammary epithelial cells uncovers regulatory principles in EMT Save
- Imaging the future: the emerging era of single‐cell spatial proteomics Save
- PDX-derived organoids model in vivo drug response and secrete biomarkers Save
- Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2 Save
- Oncogenic Mutations Rewire Signaling Pathways by Switching Protein Recruitment to Phosphotyrosine Sites Save
- The ubiquitin ligase Cullin5 SOCS2 regulates NDR1/STK38 stability and NF-κB transactivation Save
- SOCS2 (suppressor of cytokine signaling 2) Save
- CHIP Save